Polyetheretherketone/biphasic bioceramic composite coated with vascular endothelial growth factor to repair mandibular defects

doi:10.3969/j.issn.2095-4344.1505

Abstract

Abstract:

BACKGROUND: Previous studies have confirmed that polyetheretherketone/biphasic bioceramic composites have good biocompatibility, ideal porosity and mechanical properties, which can meet the repair requirements of non-load bearing bone defects.

OBJECTIVE: To further observe the effect of polyetheretherketone/biphasic bioceramic composite coated with vascular endothelial growth factor in the repair of mandibular defects.

METHODS: Thirty-six New Zealand white rabbits were randomly divided into four groups, nine in each group. The control group did not undergo any treatment. A mandibular defect model was made in the model group. The sham operation group only replicated the surgical procedure of the model group but did not make bone defects. In the scaffold group, the polyetheretherketone/biphasic bioceramic composite coated with vascular endothelial growth factor was implanted into the mandibular defect site. Mandibular specimens were taken at 4, 8, and 16 weeks after operation. Hematoxylin-eosin staining and Van Gieson staining were performed to observe the repair of bone defects. The expression of vascular endothelial growth factor was detected by PCR, western blot and immunofluorescence.

RESULTS AND CONCLUSION: (1) Hematoxylin-eosin staining results showed that the bone structure was intact in the control group and the sham operation group, and the bone defect in the model group did not change markedly within 16 weeks after operation; at 8 and 16 weeks after operation, osteoblasts appeared at the scaffold edge of the scaffold group. (2) Van Gieson staining results showed that the bone structure was intact in the control group and the sham operation group, and there was no significant change in the bone defect within 16 weeks after operation; at 8 and 16 weeks after operation, osteoblasts appeared at the scaffold edge of the scaffold group, but not collagen fibers produced. (3) At 4 weeks after operation, there was no difference in the expression of vascular endothelial growth factor among the three groups; at 8 and 16 weeks after operation, the expression of vascular endothelial growth factor in the control group was higher than that in model group (P < 0.05), but lower than that in the scaffold group (P < 0.05). In conclusion, polyetheretherketone/biphasic bioceramic composites coated with vascular endothelial growth factor to repair mandibular defects can increase the expression of vascular endothelial growth factor and promote bone regeneration.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Key words: Ceramics, Vascular Endothelial Growth Factors, Tissue Engineering

CLC Number:

R459.9

R318

Yu Hedong, Chen Yongji, Mao Min, Chen Shaojuan, Ni Xiaobing, Leng Weidong, Luo Jie. Polyetheretherketone/biphasic bioceramic composite coated with vascular endothelial growth factor to repair mandibular defects[J]. Chinese Journal of Tissue Engineering Research, 2019, 23(2): 184-189.

Figures/Tables 6

References

[1] Briem D, Strametz S, Schröoder K, et al. Response of primary fibroblasts and osteoblasts to plasma treated polyetheretherketone (PEEK) surfaces. J Materi Sci Mater Med. 2005;16(7):671-677.

[2] Dorozhkin SV. Calcium Orthophosphates in Nature, Biology and Medicine. Materials. 2009;2(2):399-498.

[3] Katzer A, Marquardt H, Westendorf J, et al. Polyetheretherketone--cytotoxicity and mutagenicity in vitro. Biomaterials. 2002;23(8):1749-1759.

[4] Converse GL, Conrad TL, Merrill CH, et al. Hydroxyapatite whisker-reinforced polyetherketoneketone bone ingrowth scaffolds. Acta Biomaterialia. 2010;6(3):856-863.

[5] Lee JH, Jang HL, Lee KM, et al. In vitro and in vivo evaluation of the bioactivity of hydroxyapatite-coated polyetheretherketone biocomposites created by cold spray technology. Acta Biomaterialia. 2013;9(4):6177.

[6] Salerno S, Piscioneri A, Laera S, et al. Improved functions of human hepatocytes on NH 3, plasma-grafted PEEK-WC–PU membranes. Biomaterials. 2009;30(26):4348-4356.

[7] Dennes TJ, Schwartz J. A Nanoscale Adhesion Layer to Promote Cell Attachment on PEEK. J Am Chem Soc. 2009; 131(10):3456-3457.

[8] Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011;42(6):551-555.

[9] Zhao D, Pan C, Sun J, et al. VEGF drives cancer-initiating stem cells through VEGFR-2|[sol]|Stat3 signaling to upregulate Myc and Sox2. Oncogene. 2015;34(24):3107.

[10] Bosch C, Melsen B, Vargervik K. Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg. 1998;9(4):310-316.

[11] Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg. 1990;1(1):60-68.

[12] Aaboe M, Pinholt EM, Hjørting-Hansen E. Unicortical critical size defect of rabbit tibia is larger than 8 mm. J Craniofac Surg. 1994;5(3):201-203.

[13] Nyman R, Magnusson M, Sennerby L, et al. Membrane- guided bone regeneration. Segmental radius defects studied in the rabbit. Acta Orthopaedica Scandinavica. 1995;66(2): 169-173.

[14] Chen G, Li W, Yu X, et al. Study of the cohesion of TTCP/DCPA phosphate cement through evolution of cohesion time and remaining percentage. J Mater Sci. 2009;44(3):828.

[15] Sayer M, Stratilatov AD, Reid J, et al. Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials. 2003;24(3):369.

[16] Reid JW, Pietak A, Sayer M, et al. Phase formation and evolution in the silicon substituted tricalcium phosphate/ apatite system. Biomaterials. 2005;26(16):2887.

[17] Jang JH, Castano O, Kim HW. Electrospun materials as potential platforms for bone tissue engineering. Adv Drug Deliv Rev. 2009;61(12):1065.

[18] Arcangeli E, Kon E, Delcogliano M, et al. Nanocomposite biomimetic scaffold in knee osteochondral defect regeneration: an animal study. J Appl Biomater Biomech. 2009;7(1):52-53.

[19] Khadka A, Li J, Li Y, et al. Evaluation of hybrid porous biomimetic nano-hydroxyapatite/polyamide 6 and bone marrow-derived stem cell construct in repair of calvarial critical size defect. J Craniofac Surg. 2011;22(5):1852-1858.

[20] Schneider OD, Weber F, Brunner TJ, et al. In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for complex defects. Acta Biomaterialia. 2009;5(5):1775-1784.

[21] Chow LC. Next generation calcium phosphate-based biomaterials. Dent Mater J. 2009;28(1):1.

[22] 冷卫东,刘彩云,黄翠,等.聚醚醚酮/牙源性双相生物陶瓷复合材料的制备及力学性能[J].中国组织工程研究, 2015,19(52): 8418-8422.

[23] Fontijn D, Bosch LJ, Duyndam MC, et al. Basic Fibroblast Growth Factor-Mediated Overexpression of Vascular Endothelial Growth Factor in 1F6 Human Melanoma Cells is Regulated by Activation of PI-3K and p38 MAPK. Cell Oncol. 2009;31(3):179-190.

[24] Park K, Amano H, Ito Y, et al. Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model. Biomed Pharmacother. 2016;78:140-149.

[25] Horner A, Bishop NJ, Bord S, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat. 1999;194(Pt 4):519-524.

[26] Becker R, Pufe T, Kulow S, et al. Expression of vascular endothelial growth factor during healing of the meniscus in a rabbit model. J Bone Joint Surg Br. 2004;86(7):1082-1087.

[27] Lilley CE, Groutsi F, Han Z, et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J Virol. 2001; 75(9):4343-4356.